23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.

23andMe Sued Over Hack of Genetic Data Affecting Thousands

23andMe to Get a Makeover After Agreement with FDA

23andMe sells $300-million stake to GlaxoSmithKline and will help develop drugs - Los Angeles Times

23andMe is on sale for 50% off today

Biden wants blood tests to detect cancer early, but it's not that easy - The Washington Post

23andMe Is Bringing DNA Sequencing for Health Risks To Consumers - Bloomberg

Bloomberg Businessweek NOV 8, 2021 The Spit-Tube Startup wants to be a big-time

23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer's (SITC) 2022 Annual Meeting

23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg

FDA warns Google-backed 23andMe to halt sales of genetic tests